Fact CheckerSign in

NCT06370845RecruitingEarly phase 1

ABUNDANCE of A NATURAL ODOUR in HUMAN CEREBROSPINAL FLUID AFTER OLFACTORY EXPOSURE - the OLFO-Brain Study

Source: ClinicalTrials.gov · Last updated 4 May 2026

Brief summary (registry, in English)

The goal of this clinical trial is to investigate the abundance of a natural odour in human cerebrospinal fluid in obese and lean participants after inhalation thereof. Participants will undergo blood sample collection and inhalation of either a natural odour or placebo through an inhaler in addition to a liquor puncture prescribed in standard of care context.

Status (registry)
Recruiting
Phase (registry)
Early phase 1
Study type
Interventional
Enrollment
32 (estimated)
First submitted
21 Mar 2024
Start date
14 Apr 2026
Primary completion date
31 Aug 2027
Lead sponsor
University Hospital, Basel, Switzerland
Diseases
Obesity
NCT number
NCT06370845

What you commit to

  • Study type: Interventional · Early phase 1
  • Planned participants: 32
  • From 14 Apr 2026 to the primary completion date, 31 Aug 2027
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Present or past surgical intervention of the nasal cavity, the paranasal sinus, the pituitary or the frontal brain

Other illness

  • Known allergy to the natural odour
  • Acute upper respiratory tract infection, acute or chronic sinusitis
  • Any kind of severe chronic disease (e.g. severe heart failure, active cancer disease, severe renal impairment with an estimated glomerular filtration rate \<30 ml/min/m2)

Other

  • Pregnancy/lactation
  • Inability to understand the study procedure and to sign the study consent

Who the study is looking for

  • Age 18-60 years
  • Written informed consent
  • Scheduled for routine liquor puncture
  • BMI ≥ 30 kg/m2
  • No proven diagnose of diabetes
  • Age 18-60 years
  • Written informed consent
  • Scheduled for routine liquor puncture
  • BMI 18-25 kg/m2

Age in the registry: 18 years to 60 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Hospital of Basel
Coordinator of this site? Confirm its status
BaselSwitzerlandRecruiting
University Hospital Basel
Coordinator of this site? Confirm its status
BaselSwitzerlandNot yet recruiting

This page is information, not medical advice. Discuss any trial with your doctor.